🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

Recruitingn/aAges 18 Years - anyAllUniversity of Edinburgh
NCT07351422 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: For the patient questionnaire: * Age ≥ 18 years * A formal diagnosis of TAK For the physician questionnaire • A physician involved in the management/decision-making for patients diagnosed with TAK Exclusion Criteria: For the patient questionnaire: * Age \< 18 years * Lack of a formal diagnosis of TAK * Patients without mental capacity or willingness to provide informed consent * Not UK based For the physician questionnaire * Not involved in the management/ decision making for patients diagnosed with TAK * Not willing to take part * Not UK based
💊

What it tests

  • Questionnaire
📍

Where

1 site
University of Edinburgh
Edinburgh, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy